• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

c.455C>T p.(Pro152Leu) 致病变异是一种低风险等位基因,其患乳腺癌和肉瘤的风险较低。

c.455C>T p.(Pro152Leu) pathogenic variant is a lower risk allele with attenuated risks of breast cancer and sarcoma.

作者信息

Evans D Gareth, Harkness Elaine F, Woodward Emma R

机构信息

Division of Evolution, Infection and Genomics, School of Biological Sciences, Faculty of Biology, Medicine and Health, The University of Manchester, Manchester, UK

Manchester Centre for Genomic Medicine, Manchester University NHS Foundation Trust, Manchester, UK.

出版信息

J Med Genet. 2023 Nov;60(11):1057-1060. doi: 10.1136/jmg-2022-109133. Epub 2023 Apr 19.

DOI:10.1136/jmg-2022-109133
PMID:37076289
Abstract

Germline (likely) pathogenic variants cause Li-Fraumeni syndrome (LFS), typically associated with sarcoma, brain, breast and adrenal tumours. Although classical LFS is highly penetrant, the p.R337H variant, common in Brazil, is typically associated with childhood adrenal tumours and an older onset age of other LFS tumours. Previously, we reported the finding of p.P152L in 6 children from 5 families with adrenal tumours. We have now assessed cancer risks over the subsequent 23 years, and in one further family with p.P152L. Cancer risks were compared with those in the 11 families known to our service with classical dominant negative mutations affecting neighbouring codons 245 and 248 (codon 245/248).Compared with codon 245/248 families, we found lower age-related risks for all non-adrenal tumours in codon 152 families (p<0.0001) with an absence of breast cancer as compared with 100% penetrance by age 36 years in codon 245/248 families (p<0.0001), and lower rates of sarcoma in non-irradiated individuals (p=0.0001). Although there were more adrenal tumours in codon 152 families (6/26 individuals, 1/27 for codon 245/248), this was not significant (p=0.05).Understanding codon-specific cancer risks in LFS is important for accurate personalised cancer risk assessment, and subsequent prevention and early detection strategies.

摘要

种系(可能)致病性变异导致李-弗劳梅尼综合征(LFS),通常与肉瘤、脑肿瘤、乳腺癌和肾上腺肿瘤相关。虽然经典的LFS具有高度的外显率,但在巴西常见的p.R337H变异通常与儿童肾上腺肿瘤以及其他LFS肿瘤的发病年龄较大有关。此前,我们报告了在来自5个肾上腺肿瘤家庭的6名儿童中发现了p.P152L。我们现在评估了随后23年的癌症风险,并对另一个有p.P152L的家庭进行了评估。将癌症风险与我们服务机构已知的11个具有影响相邻密码子245和248(密码子245/248)的经典显性负性突变的家庭进行了比较。与密码子245/248家庭相比,我们发现密码子152家庭中所有非肾上腺肿瘤的年龄相关风险较低(p<0.0001),与密码子245/248家庭在36岁时100%的外显率相比,不存在乳腺癌(p<0.0001),并且未受辐射个体中的肉瘤发生率较低(p=0.0001)。虽然密码子152家庭中的肾上腺肿瘤更多(26名个体中有6例,密码子245/248家庭为27名个体中有1例),但这并不显著(p=0.05)。了解LFS中密码子特异性的癌症风险对于准确的个性化癌症风险评估以及后续的预防和早期检测策略很重要。

相似文献

1
c.455C>T p.(Pro152Leu) pathogenic variant is a lower risk allele with attenuated risks of breast cancer and sarcoma.c.455C>T p.(Pro152Leu) 致病变异是一种低风险等位基因,其患乳腺癌和肉瘤的风险较低。
J Med Genet. 2023 Nov;60(11):1057-1060. doi: 10.1136/jmg-2022-109133. Epub 2023 Apr 19.
2
Clinical spectrum of Li-Fraumeni syndrome/Li-Fraumeni-like syndrome in Brazilian individuals with the TP53 p.R337H mutation.巴西个体中 TP53 p.R337H 突变的 Li-Fraumeni 综合征/Li-Fraumeni 样综合征的临床谱。
J Steroid Biochem Mol Biol. 2019 Jun;190:250-255. doi: 10.1016/j.jsbmb.2019.04.011. Epub 2019 Apr 8.
3
Li-Fraumeni and Li-Fraumeni-like syndrome among children diagnosed with pediatric cancer in Southern Brazil.巴西南部儿童癌症患者中李-佛美尼综合征和李-佛美尼样综合征。
Cancer. 2013 Dec 15;119(24):4341-9. doi: 10.1002/cncr.28346. Epub 2013 Oct 7.
4
The TP53 mutation, R337H, is associated with Li-Fraumeni and Li-Fraumeni-like syndromes in Brazilian families.TP53基因的R337H突变与巴西家族中的李-佛美尼综合征及李-佛美尼样综合征相关。
Cancer Lett. 2007 Jan 8;245(1-2):96-102. doi: 10.1016/j.canlet.2005.12.039. Epub 2006 Feb 21.
5
Medical guidelines for Li-Fraumeni syndrome 2019, version 1.1.2019 年 1.1 版李-佛美尼综合征医学指南
Int J Clin Oncol. 2021 Dec;26(12):2161-2178. doi: 10.1007/s10147-021-02011-w. Epub 2021 Oct 11.
6
Comparable frequency of BRCA1, BRCA2 and TP53 germline mutations in a multi-ethnic Asian cohort suggests TP53 screening should be offered together with BRCA1/2 screening to early-onset breast cancer patients.在一个多民族亚洲队列中,BRCA1、BRCA2 和 TP53 种系突变的频率相当,这表明应向早发性乳腺癌患者提供与 BRCA1/2 筛查相结合的 TP53 筛查。
Breast Cancer Res. 2012 Apr 16;14(2):R66. doi: 10.1186/bcr3172.
7
TP53 p.R337H prevalence in a series of Brazilian hereditary breast cancer families.一系列巴西遗传性乳腺癌家族中TP53 p.R337H的患病率
Hered Cancer Clin Pract. 2014 Mar 13;12(1):8. doi: 10.1186/1897-4287-12-8.
8
Breast Cancer Phenotype Associated With Li-Fraumeni Syndrome: A Brazilian Cohort Enriched by p.R337H Carriers.与李-弗劳梅尼综合征相关的乳腺癌表型:一个富含p.R337H携带者的巴西队列
Front Oncol. 2022 Mar 16;12:836937. doi: 10.3389/fonc.2022.836937. eCollection 2022.
9
Frequency of Thyroid Carcinoma in Brazilian TP53 p.R337H Carriers With Li Fraumeni Syndrome.巴西 TP53 p.R337H 携带者中 Li-Fraumeni 综合征的甲状腺癌频率。
JAMA Oncol. 2017 Oct 1;3(10):1400-1402. doi: 10.1001/jamaoncol.2016.6389.
10
TP53 germline mutation testing in 180 families suspected of Li-Fraumeni syndrome: mutation detection rate and relative frequency of cancers in different familial phenotypes.180 个疑似李-佛美尼综合征家族的 TP53 种系突变检测:不同家族表型中癌症的突变检出率和相对频率。
J Med Genet. 2010 Jun;47(6):421-8. doi: 10.1136/jmg.2009.073429.

引用本文的文献

1
Personalized screening strategies for R337H carriers: a retrospective cohort study of tumor spectrum in Li-Fraumeni syndrome adult carriers.R337H携带者的个性化筛查策略:李-弗劳梅尼综合征成年携带者肿瘤谱的回顾性队列研究
Lancet Reg Health Am. 2025 Jan 18;42:100982. doi: 10.1016/j.lana.2024.100982. eCollection 2025 Feb.
2
Cancer Risks Associated With Pathogenic Variants: Maximum Likelihood Analysis of Extended Pedigrees for Diagnosis of First Cancers Beyond the Li-Fraumeni Syndrome Spectrum.与致病性变异相关的癌症风险:Li-Fraumeni 综合征谱之外的首发癌症的扩展家系的最大似然分析。
JCO Precis Oncol. 2024 Feb;8:e2300453. doi: 10.1200/PO.23.00453.
3
Cancer Precision-Prevention trial of Metformin in adults with Li Fraumeni syndrome (MILI) undergoing yearly MRI surveillance: a randomised controlled trial protocol.
Li Fraumeni 综合征成人接受每年 MRI 监测的二甲双胍癌症精准预防试验(MILI):一项随机对照试验方案。
Trials. 2024 Feb 3;25(1):103. doi: 10.1186/s13063-024-07929-w.